ResultsIQ

ResultsIQ › Latest results › Indegene Limited

Indegene Limited Q2 FY27 results deck summary

NSE: INDGN · BSE: 544172

Results deck of 29 Oct 2026, summarised by AI from the filing.

Q2 FY27 revenue ₹11,223 M, up 39.5% YoY, with EBITDA margin at 16.7% and management guiding EBITDA to grow faster than revenue ahead.

Key takeaways

  1. Revenue growth Q2 FY27 revenue from operations ₹11,223 M, up 39.5% YoY and 5.6% QoQ, the fifth successive quarter above 5% sequential growth.
  2. Client additions $1M+ clients rose to 59 from 40 in Q2 FY26, with 19 new additions, and active clients reached 107.
  3. Top accounts Deeper penetration of top accounts drove growth, with Top-10 clients revenue up 13.5% QoQ.
  4. Yield pressure The US rate hike cut Q2 yield by 90 bps on PBT and 70 bps on PAT.

Original filing on BSE

Indegene Limited Q2 FY27 results

As filed: Revenue ₹1,122 cr (+40% year on year), EBITDA ₹186 cr (+33% year on year), PAT ₹112 cr (+10% year on year), EBITDA margin 16.6% (−87 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹1,063 cr (+40% year on year), EBITDA ₹174 cr (+12% year on year), PAT ₹116 cr (0% year on year), EBITDA margin 16.4% (−411 bps). Score 55 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin fell 411 bps year on year. Revenue rose ₹302 cr on a year ago, more than the ₹84.0 cr it added the year before. Share price after the results: +12.5% in 29 days (Nifty 500: +0.7%).
  • Q4 FY26: Revenue ₹1,003 cr (+33% year on year), EBITDA ₹164 cr (+11% year on year), PAT ₹79.7 cr (−16% year on year), EBITDA margin 16.3% (−314 bps). Score 41 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit before exceptional items growth was well below it. EBITDA margin fell 314 bps year on year. Consolidated profit -32% but standalone +34%. Profit fell 7% from last quarter. Revenue rose ₹247 cr on a year ago, more than the ₹83.0 cr it added the year before. Share price after the results: +5.3% in 30 days (Nifty 500: −0.9%).
  • Q3 FY26: Revenue ₹942 cr (+31% year on year), EBITDA ₹160 cr (+22% year on year), PAT ₹103 cr (−6% year on year), EBITDA margin 16.9% (−126 bps). Score 56 of 100, In line with trend. EBITDA margin fell 126 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: +5.7% in 29 days (Nifty 500: +0.1%).
  • Q2 FY26: Revenue ₹804 cr (+17% year on year), EBITDA ₹140 cr (+11% year on year), PAT ₹102 cr (+11% year on year), EBITDA margin 17.4% (−93 bps). Score 51 of 100, In line with trend. EBITDA margin fell 93 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 12% from last quarter. Share price after the results: −3.8% in 29 days (Nifty 500: +0.4%).
  • Q1 FY26: Revenue ₹761 cr (+12% year on year), EBITDA ₹156 cr (+21% year on year), PAT ₹116 cr (+32% year on year), EBITDA margin 20.5% (+144 bps). Score 65 of 100, Above trend. EBITDA margin rose 144 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: −0.1% in 29 days (Nifty 500: −2.0%).
  • Q4 FY25: Revenue ₹756 cr (+12% year on year), EBITDA ₹147 cr (+5% year on year), PAT ₹118 cr (+24% year on year), EBITDA margin 19.4% (−136 bps). Score 49 of 100, In line with trend. EBITDA margin fell 136 bps year on year. Not enough history for a trend yet: scored on growth alone. Share price after the results: +2.8% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹720 cr, EBITDA ₹131 cr, PAT ₹110 cr, EBITDA margin 18.2%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹720 cr). Scored once a year-earlier consolidated quarter exists.

Past price moves after results do not indicate future moves. Not a recommendation.

Indegene Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.